The transactions highlighted below are representative of Greenhill engagements. In addition, the Firm has completed many engagements that were not publicly-disclosed.
Recent Transactions
Sort By
21-Jan-15
$3.0 billion
Target:
Hiland Partners, LP
Acquiror:
Kinder Morgan, Inc.
Advised Hiland Partners, a leading midstream energy company with operations primarily in the Bakken Shale, on its sale to Kinder Morgan, North America’s largest energy infrastructure company
19-Dec-14
$NA
Target:
NYK Ports LLC
Acquiror:
Macquarie Infrastructure Partners
Advised NYK Ports LLC, a leading port operating and stevedoring company, on the sale of a 49% stake to Macquarie Infrastructure Partners, a leading Australian infrastructure fund
12-Nov-14
$175 million
Target:
Voya Financial, Inc.
Acquiror:
Voya Financial, Inc.
Advised the Independent Committee of the Board of Directors of Voya Financial, Inc. in connection with Voya Financial, Inc.’s repurchase of 4.5mm shares (aggregate repurchase of $175mm) from ING Groep N.V.
03-Sep-14
$300 million
Target:
Voya Financial, Inc.
Advised the Independent Committee of the Board of Directors of Voya Financial, Inc. in connection with Voya Financial, Inc.’s repurchase of 7.7mm shares (aggregate repurchase of $300mm) from ING Groep N.V.
11-Aug-14
$NA
Target:
MannKind Corporation
Acquiror:
Sanofi
Advised MannKind, a biopharmaceutical company focused on the development of therapeutic products for patients with diabetes, on a collaboration with Sanofi, comprising licensing, supply and loan facility agreements with respect to licensing the Company’s lead product AFREZZA. MannKind will receive up to $925 million in upfront and milestone payments plus 35% of future profits.
05-Aug-14
$1.3 billion
Target:
Siemens Health Services
Acquiror:
Cerner Corporation
Advised Cerner Corporation, a leader in healthcare information services, on the acquisition of the assets of Siemens Aktiengesellschaft’s healthcare information technology business unit, Siemens Health Services, for $1.3 billion in cash.
28-Jul-14
$90 million
Target:
Clinuvel Pharmaceuticals Limited
Acquiror:
Retrophin, Inc.
Advised Clinuvel, a biopharmaceutical company focused on developing drugs for the treatment of a range of severe skin disorders, in response to an unsolicited proposal to acquire the business from Retrophin, a pharmaceutical company focused on the development, acquisition and commercialization of drugs for the treatment of serious, catastrophic or rare diseases
24-Jul-14
$3.0 billion
Target:
QR Energy, LP
Acquiror:
BreitBurn Energy Partners LP
Advised QR Energy, LP on the merger with Breitburn Energy Partners LP to create the largest oil-weighted MLP in the upstream oil & gas sector
26-Jun-14
$2.7 billion
Target:
Frank Russell Company
Acquiror:
London Stock Exchange Group plc
Advised LSEG on the proposed acquisition of Frank Russell Company, the number one provider of benchmarks to US-focused equity funds and a leading provider of multi-asset class investment solutions, from Northwestern Mutual Life Insurance Company, including acting as Joint Sponsor to LSEG on its $1.6 billion rights issue
23-Jun-14
$690 million
Target:
Western World Insurance Group, Inc.
Acquiror:
Validus Holdings, Ltd.
Advised Validus Holdings, Ltd., a leading Bermuda-based provider of reinsurance, insurance, and insurance linked securities management, on its acquisition of Western World Insurance Group, Inc., a specialty US commercial insurer
15-Apr-14
$NA
Target:
MGM Hakkasan Hospitality
Advised MGM Resorts International on the formation of a joint venture hotel management company with the Hakkasan Group called MGM Hakkasan Hospitality that will design, develop and manage luxury non-gaming hotels worldwide
01-Apr-14
$NA
Target:
Dillard's, Inc. (Credit Card Assets)
Acquiror:
Wells Fargo & Company
Advised Dillard’s, Inc. on a strategic alliance relating to its credit card business with Wells Fargo & Company
25-Mar-14
$250 million
Target:
ING US, Inc.
Advised the Independent Committee of the Board of Directors of ING US, Inc. in connection with ING U.S., Inc’s repurchase of 7.2mm shares (aggregate repurchase of $250mm) from ING Groep N.V.
18-Feb-14
$25.1 billion
Target:
Forest Laboratories Inc.
Acquiror:
Actavis plc
Advised Actavis plc, a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products on its acquisition of Forest Laboratories Inc.
05-Feb-14
$NA
Target:
Unfors Raysafe AB
Acquiror:
Fluke Biomedical Corporation
Advised the Sixth Swedish National Pension Fund on the sale of Unfors Raysafe AB, a provider of easy-to-use products that help to reduce unnecessary radiation exposure, to Fluke Biomedical Corp., a subsidiary of Danaher Corp. that manufactures biomedical test and simulation products
18-Dec-13
$NA
Target:
Fidelis SeniorCare Inc. (Michigan Heath Plan)
Acquiror:
Centene Corporation
Advised Fidelis SeniorCare Inc., a healthcare provider focused on the care of the elderly, on the sale of a majority of its SecureCare Michigan health plan to Centene Corporation, a managed care provider focused on the Medicaid space
04-Nov-13
$4.9 billion
Target:
Berry Petroleum Co.
Acquiror:
LINN Energy, LLC
Advised the Independent Directors of LINN Energy, LLC, the largest oil & gas upstream MLP, related to the amended terms of the acquisition of Berry Petroleum Company
21-Oct-13
$4.8 billion
Target:
Devon Energy Corporation (US Midstream Assets)
Acquiror:
Crosstex Energy, Inc. & Crosstex Energy, L.P.
Advised Crosstex Energy, Inc. & Crosstex Energy, L.P., a leading US based midstream company, on the creation of a new midstream energy partnership with Devon Energy Corporation, a top-five US independent exploration & production company
03-Sep-13
$830 million
Target:
American Roads LLC
Advised American Roads LLC, the operator of five toll road facilities in the United States and Canada, in connection with its pre-arranged Chapter 11 proceedings
17-Jul-13
$600 million
Target:
Lincoln Benefit Life, a subsidiary of the Allstate Corporation
Acquiror:
Resolution Life Holdings
Advised the limited partners of Resolution Life L.P. in the proposed acquisition by its subsidiary, Resolution Life Holdings, Inc., of Lincoln Benefit Life for $600mm
17-Jun-13
$200 million
Target:
Tesoro Hawaii, LLC
Acquiror:
Par Petroleum
Advised the Special Committee of the Board of Directors of Par Petroleum in connection with its acquisition of Tesoro Hawaii, LLC from Tesoro Corporation
12-Jun-13
$893 million
Target:
A$1.6bn non-core loan portfolio
Acquiror:
Goldman Sachs Group. Inc.
Advised Suncorp Group Ltd (ASX:SUN), a leading general insurance, retail banking and life insurance group in Australia and New Zealand, on the sale of a A$1.6bn portfolio of performing and non-performing (corporate and property) loans to Goldman Sachs Group Inc., an American multinational investment banking firm
20-May-13
$8.5 billion
Target:
Warner Chilcott, plc
Acquiror:
Actavis, Inc.
Advised Actavis, Inc., a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, branded and biosimilar products on its acquisition of Warner Chilcott plc
08-May-13
$110 million
Target:
Healthcare Finance Group, LLC
Acquiror:
Fifth Street Finance Corp.
Advised Fifth Street Finance Corp., a specialty finance company with approximately $2 billion of assets under management, on the acquisition of Healthcare Finance Group, LLC, a specialty lender providing asset-based lending and term loan products to the healthcare industry
06-May-13
~$7.0 billion
Target:
Crestwood Midstream Partners LP
Acquiror:
Inergy, L.P. / Inergy Midstream L.P.
Advised Inergy, a leading diversified midstream energy company, and its affiliates on their merger with Crestwood Midstream Partners LP and affiliates